Evidence for a halothane-induced reduction in maximal calcium-activated force in mammalian myocardium.
Berman
M R
MR
Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Hospital, Baltimore, Maryland 21205.
Casella
E S
ES
Blanck
T J
TJ
D008841:Actin Cytoskeleton / Q000187:drug effects; D000818:Animals; D002118:Calcium / Q000502:physiology*; D003864:Depression, Chemical; D004558:Electric Stimulation; D006221:Halothane / Q000494:pharmacology*; D066298:In Vitro Techniques; D008297:Male; D009200:Myocardial Contraction / Q000187:drug effects*; D010210:Papillary Muscles / Q000187:drug effects / Q000502:physiology; D011817:Rabbits; D012433:Ryanodine / Q000494:pharmacology; D012508:Sarcolemma / Q000187:drug effects; D012519:Sarcoplasmic Reticulum / Q000187:drug effects
D012433:Ryanodine; D002118:Calcium; D006221:Halothane